BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
41.73
+1.73 (4.32%)
At close: Jun 20, 2025, 4:00 PM
41.69
-0.04 (-0.10%)
After-hours: Jun 20, 2025, 7:57 PM EDT

BridgeBio Pharma Statistics

Total Valuation

BBIO has a market cap or net worth of $7.92 billion. The enterprise value is $9.24 billion.

Market Cap 7.92B
Enterprise Value 9.24B

Important Dates

The next estimated earnings date is Thursday, July 31, 2025, before market open.

Earnings Date Jul 31, 2025
Ex-Dividend Date n/a

Share Statistics

BBIO has 189.88 million shares outstanding. The number of shares has increased by 11.59% in one year.

Current Share Class 189.88M
Shares Outstanding 189.88M
Shares Change (YoY) +11.59%
Shares Change (QoQ) +0.37%
Owned by Insiders (%) 4.37%
Owned by Institutions (%) 77.79%
Float 146.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 61.88
Forward PS 18.42
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 72.53
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.57

Current Ratio 4.57
Quick Ratio 4.31
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5.67

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -48.27%
Return on Invested Capital (ROIC) -91.66%
Return on Capital Employed (ROCE) -91.62%
Revenue Per Employee $174,541
Profits Per Employee -$915,025
Employee Count 730
Asset Turnover 0.15
Inventory Turnover n/a

Taxes

In the past 12 months, BBIO has paid $1.15 million in taxes.

Income Tax 1.15M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +51.14% in the last 52 weeks. The beta is 1.10, so BBIO's price volatility has been similar to the market average.

Beta (5Y) 1.10
52-Week Price Change +51.14%
50-Day Moving Average 35.94
200-Day Moving Average 31.07
Relative Strength Index (RSI) 69.81
Average Volume (20 Days) 2,723,349

Short Selling Information

The latest short interest is 21.99 million, so 11.58% of the outstanding shares have been sold short.

Short Interest 21.99M
Short Previous Month 22.40M
Short % of Shares Out 11.58%
Short % of Float 15.04%
Short Ratio (days to cover) 6.62

Income Statement

In the last 12 months, BBIO had revenue of $127.42 million and -$667.97 million in losses. Loss per share was -$3.54.

Revenue 127.42M
Gross Profit 121.50M
Operating Income -668.41M
Pretax Income -453.82M
Net Income -667.97M
EBITDA -662.65M
EBIT -668.41M
Loss Per Share -$3.54
Full Income Statement

Balance Sheet

The company has $540.60 million in cash and $1.86 billion in debt, giving a net cash position of -$1.32 billion or -$6.94 per share.

Cash & Cash Equivalents 540.60M
Total Debt 1.86B
Net Cash -1.32B
Net Cash Per Share -$6.94
Equity (Book Value) -1.64B
Book Value Per Share -8.68
Working Capital 543.07M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$500.42 million and capital expenditures -$238,000, giving a free cash flow of -$500.66 million.

Operating Cash Flow -500.42M
Capital Expenditures -238,000
Free Cash Flow -500.66M
FCF Per Share -$2.64
Full Cash Flow Statement

Margins

Gross Margin 95.35%
Operating Margin -524.60%
Pretax Margin -530.27%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.59%
Shareholder Yield -11.59%
Earnings Yield -8.43%
FCF Yield -6.32%
Dividend Details

Analyst Forecast

The average price target for BBIO is $56.67, which is 35.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target $56.67
Price Target Difference 35.80%
Analyst Consensus Strong Buy
Analyst Count 13
Revenue Growth Forecast (5Y) 61.22%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BBIO has an Altman Z-Score of -5.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.54
Piotroski F-Score 1